Radiomic Trajectory Quantifies Early Lung Adenocarcinoma Progression
- Artificial intelligence
- 21/11/2025
Accurately determining progression in early-stage lung adenocarcinoma (esLUAD) is central to diagnosis, treatment selection and follow-up, yet conventional grading can m
READ MORE